Series B Investors & VC Firms in Germany
133 firms in this list, with a median first check of $545K. 12 of them lead rounds. Generated from verified public data and updated continuously.
EDB Investments
Seed–Series B
11 people
Hi Inov
LyonSeed–Series B$540K – $10.8M
8 people
6 Degrees Capital
LondonSeed–Series B$1.1M – $5.4M
8 people
Eurazeo
ParisSeries A–Late Stage
11 people
SingTel Innov8 Pte Ltd.
Seed–Series B$80K – $25M
8 people
TVM Capital
MunchenSeed–Late Stage$1.1M – $16.2M
8 people
Target Partners
MunichSeed–Late Stage$1.1M – $3.2M
7 people
Edenred Ventures
LondonSeed–Series B$540K – $5.4M
7 people
Extens
ParisSeries A–Series B$3.2M – $16.2M
7 people
Future Energy Ventures
BerlinSeed–Late Stage$1.1M – $5.4M
7 people
Karista
ParisPre-Seed–Late Stage$324K – $5.4M
7 people
LBBW Venture Capital GmbH
StuttgartSeed–Late Stage$540K – $5.4M
7 people
Milano Investment Partners SGR
MilanSeed–Late Stage
10 people
Red River West
ParisSeries A–Series B$5.4M – $54M
7 people
Shift4Good
ParisSeries A–Series B$540K – $21.6M
7 people
UNIQA Ventures GmbH
ViennaSeed–Series B$1.1M – $5.4M
7 people
Forbion
AmsterdamPre-Seed–Late Stage
1 person
3VC
ViennaSeries A–Late Stage$1.1M
6 people
Airbridge Equity Partners
AmsterdamSeries A–Series B$1.1M – $5.4M
6 people
Ajax Health
Menlo ParkSeed–Late Stage
9 people
BioMedPartners
BaselSeed–Late Stage$648K – $6.5M
6 people
Boehringer Ingelheim Venture Fund
Ingelheim am RheinSeed–Series B$16.2M
9 people
bValue Venture Capital
WarsawSeed–Late Stage$270K – $16.2M
6 people
Deutsche Borse
EschbornSeries A–Late Stage$5.4M – $27M
6 people
Related lists
Seed Investors & VC Firms (7051)Series A Investors & VC Firms (4959)Investors & VC Firms in United States (2654)Series B Investors & VC Firms (2615)Pre-Seed Investors & VC Firms (2349)Late Stage Investors & VC Firms (2244)Seed Investors & VC Firms in United States (2211)Series A Investors & VC Firms in United States (2107)Growth Investors & VC Firms (1963)Series C Investors & VC Firms (1701)
Data sourced from public filings and firms' own websites — see our methodology.